Trademark: 87523267
Status Date
Tuesday, April 2, 2019
Registration Number
5712036
Registration Date
Tuesday, April 2, 2019
Filing Date
Tuesday, July 11, 2017
Published for Opposition
Tuesday, January 15, 2019
5 Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases
16 Pharmaceutical information leaflets; Printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets and newsletters for providing medical, pharmaceutical and scientific research information
1 Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use other than for medical purposes; Diagnostic preparations for clinical or medical laboratory use
44 Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
31 Transgenic live animals and live plants for research and for the production of pharmaceutical, veterinary and biochemical goods
42 Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission
Apr 2, 2024
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jan 29, 2020
Automatic Update Of Assignment Of Ownership
Aug 16, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Aug 16, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 2, 2019
Registered-Principal Register
Jan 15, 2019
Official Gazette Publication Confirmation E-Mailed
Jan 15, 2019
Published For Opposition
Dec 26, 2018
Notification Of Notice Of Publication E-Mailed
Nov 27, 2018
Withdrawn From Pub - Og Review Query
Nov 14, 2018
Electronic Record Review Complete
Nov 9, 2018
On Hold - Electronic Record Review Required
Oct 29, 2018
Case Returned To Examination
Oct 29, 2018
Notice Of Allowance Cancelled
Oct 22, 2018
Petition To Director - Change Basis - Granted
Oct 15, 2018
Assigned To Petition Staff
Sep 27, 2018
Teas Petition To Amend Basis Received
Jul 24, 2018
Noa E-Mailed - Sou Required From Applicant
May 29, 2018
Official Gazette Publication Confirmation E-Mailed
May 29, 2018
Published For Opposition
May 9, 2018
Notification Of Notice Of Publication E-Mailed
Apr 20, 2018
Electronic Record Review Complete
Apr 13, 2018
On Hold - Electronic Record Review Required
Apr 8, 2018
Approved For Pub - Principal Register
Mar 19, 2018
Examiner's Amendment Entered
Mar 19, 2018
Notification Of Examiners Amendment E-Mailed
Mar 19, 2018
Examiners Amendment E-Mailed
Mar 19, 2018
Examiners Amendment -Written
Oct 13, 2017
Notification Of Non-Final Action E-Mailed
Oct 13, 2017
Non-Final Action E-Mailed
Oct 13, 2017
Non-Final Action Written
Oct 8, 2017
Assigned To Examiner
Jul 17, 2017
New Application Office Supplied Data Entered
Jul 14, 2017
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
